Genetic Polymorphisms of the E-Cadherin Promoter and Risk of Sporadic Gastric Carcinoma in Chinese Populations
暂无分享,去创建一个
J. Ji | D. Deng | K. Pan | Zhao-jun Liu | Jing Zhou | L. Gu | W. You | Baozhen Zhang | Jun‐ling Ma
[1] B. Fernandez,et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. , 2007, JAMA.
[2] M. Gail,et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. , 2006, Journal of the National Cancer Institute.
[3] Xing Liu,et al. [Association of -160(C-->A) polymorphism in CDH1 gene with gastric cancer risk in Fujian Chinese population]. , 2005, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.
[4] H. Grönberg,et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP , 2005, Human Genetics.
[5] Jiang He,et al. Major causes of death among men and women in China. , 2005, The New England journal of medicine.
[6] W. Guo,et al. [Correlation of E-cadherin polymorphisms to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. , 2005, Ai zheng = Aizheng = Chinese journal of cancer.
[7] Lin He,et al. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.
[8] Yao-chu Xu,et al. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. , 2005, World journal of gastroenterology.
[9] Jae-Hyun Park,et al. The E-cadherin -347G->GA promoter polymorphism and its effect on transcriptional regulation. , 2004, Carcinogenesis.
[10] W. Park,et al. A single nucleotide polymorphism in the E-cadherin gene promoter-160 is not associated with risk of Korean gastric cancer. , 2003, Journal of Korean medical science.
[11] H. Yokozaki,et al. Correlation of a single nucleotide polymorphism in the E-cadherin gene promoter with tumorigenesis and progression of gastric carcinoma in Japan. , 2003, International journal of oncology.
[12] T. Merriman,et al. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer , 2002, Oncogene.
[13] C. Caldas,et al. CDH1 c‐160a promotor polymorphism is not associated with risk of stomach cancer , 2002, International journal of cancer.
[14] K. Kaneko,et al. Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. , 2002, Mutation research.
[15] E. Fearon,et al. The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.
[16] Chien-Jen Chen,et al. Association of the −160 C → a promoter polymorphism of E‐cadherin gene with gastric carcinoma risk , 2002, Cancer.
[17] W. Bodmer,et al. An insight into the genetic pathway of adenocarcinoma of the small intestine , 2002, Gut.
[18] C. Caldas,et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma , 2001, Oncogene.
[19] M. Blaser,et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. , 2000, Journal of the National Cancer Institute.
[20] D. Deng,et al. progress of gastric cancer etiology: N-nitrosamides 1999s. , 2000, World journal of gastroenterology.
[21] P. Carroll,et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. , 2000, Cancer research.
[22] A. G. Herreros,et al. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.
[23] E. Fearon,et al. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements , 1999, Oncogene.
[24] M. Gail,et al. Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer , 1999, International journal of cancer.
[25] Anthony E. Reeve,et al. E-cadherin germline mutations in familial gastric cancer , 1998, Nature.
[26] I. Tomlinson,et al. Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. , 1997, Gut.
[27] M. Blaser,et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[28] M. Vijver,et al. E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.
[29] S. Hirohashi,et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] I. Pogribny,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995 .
[31] N. Lemoine,et al. Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.
[32] H. Höfler,et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. , 1994, Cancer research.
[33] A. Kinsella,et al. Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines , 1994, Clinical & Experimental Metastasis.
[34] M. Quintanilla,et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. , 1993, The American journal of pathology.
[35] W. Birchmeier,et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. , 1993, Cancer research.
[36] W. Blot,et al. Precancerous gastric lesions in a population at high risk of stomach cancer. , 1993, Cancer research.
[37] W. Isaacs,et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.
[38] M. Takeichi,et al. Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.
[39] B. Henderson,et al. Diet and high risk of stomach cancer in Shandong, China. , 1988, Cancer research.
[40] humAn cArcinogens,et al. iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns , 2012 .
[41] Heinz Höfler,et al. Mutations of the human E‐cadherin (CDH1) gene , 1998, Human mutation.
[42] N. Muñoz,et al. Chemoprevention of stomach cancer. , 1996, IARC scientific publications.
[43] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.